Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon alpha-2a: progressive decrease in hepatitis B surface antigen in responders

Rijckborst, Vincent; Ferenci, Peter; Akdogan, Meral; Pinarbasi, Binnur; ter Borg, Martijn; Simon, Krzysztof; Flisiak, Robert; AKARCA, ULUS; Raptopoulou-Gigi, Maria; Verhey, Elke; van Vuuren, Anneke; Boucher, Charles; Hansen, Bettina; Janssen, Harry

doi:10.1097/meg.0b013e3283557e23

Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon alpha-2a: progressive decrease in hepatitis B surface antigen in responders

Atıf İçin Kopyala

Rijckborst V., Ferenci P., Akdogan M., Pinarbasi B., ter Borg M. J., Simon K., ...Daha Fazla

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, cilt.24, sa.9, ss.1012-1019, 2012 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 24 Sayı: 9
Basım Tarihi: 2012
Doi Numarası: 10.1097/meg.0b013e3283557e23
Dergi Adı: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1012-1019
İstanbul Üniversitesi Adresli: Evet

Özet

Objective Peginterferon (PEG-IFN) is considered as a first-line treatment option for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B. We aimed to evaluate the long-term response to PEG-IFN in HBeAg-negative patients.